TY - JOUR
T1 - Kinetics of the T-cell receptor CD4 and CD8 Vβ repertoire in HIV-1 vertically infected infants early treated with HAART
AU - Romiti, Maria Luisa
AU - Cancrini, Caterina
AU - Castelli-Gattinara, Guido
AU - Di Cesare, Silvia
AU - Ciaffi, Patrizia
AU - Bernardi, Stefania
AU - De Gasperi, Marco Rossi
AU - Halapi, Eva Charlotte
AU - Rossi, Paolo
PY - 2001/11/9
Y1 - 2001/11/9
N2 - Objectives: To determine the kinetics and the relationship between the T-cell receptor Vβ (TCRBV) complementary determining region 3 length, the CD4 T-cell count and HIV viral load changes in HIV-1 infected infants treated early with highly active antiretroviral therapy (HAART) during 1 year of follow-up. Design: Two HIV-1 vertically infected infants, two HIV-1 vertically exposed uninfected and two healthy controls were analysed by spectratyping. Evaluation of viral load, CD4 naive and memory cell counts and a proliferation test were also carried out. Methods: Twenty-six families and subfamilies of the TCR on CD4 and CD8 T cells were analyzed by spectratyping. Flow cytometric analysis on peripheral blood mononuclear cells for CD4CD45Ra, CD4CD45Ro, CD8CD38, proliferation tests and plasma viral load measurements were performed at baseline, 1, 6 and after 12 months of therapy. Results: HAART induced a marked reduction of viral load in both HIV-1 infected infants and an increase to normal CD4 T-cell count in the symptomatic infant. At baseline the TCRBV family distribution in the majority of CD8 and a few of the CD4 T cells was highly perturbed, with several TCRBV families showing a monoclonal/oligoclonal distribution. During HAART a normalization of the TCR repertoire in both CD8 and CD4 subsets occurred. TCR repertoire normalization was associated with a good virological and immunological response. Conclusion: These results suggest that complete and early virus replication control as a result of early HAART leads to a marked reduction of T-cell oligoclonality and is an essential prerequisite to the development of a polyclonal immune response in HIV-1 infected infants.
AB - Objectives: To determine the kinetics and the relationship between the T-cell receptor Vβ (TCRBV) complementary determining region 3 length, the CD4 T-cell count and HIV viral load changes in HIV-1 infected infants treated early with highly active antiretroviral therapy (HAART) during 1 year of follow-up. Design: Two HIV-1 vertically infected infants, two HIV-1 vertically exposed uninfected and two healthy controls were analysed by spectratyping. Evaluation of viral load, CD4 naive and memory cell counts and a proliferation test were also carried out. Methods: Twenty-six families and subfamilies of the TCR on CD4 and CD8 T cells were analyzed by spectratyping. Flow cytometric analysis on peripheral blood mononuclear cells for CD4CD45Ra, CD4CD45Ro, CD8CD38, proliferation tests and plasma viral load measurements were performed at baseline, 1, 6 and after 12 months of therapy. Results: HAART induced a marked reduction of viral load in both HIV-1 infected infants and an increase to normal CD4 T-cell count in the symptomatic infant. At baseline the TCRBV family distribution in the majority of CD8 and a few of the CD4 T cells was highly perturbed, with several TCRBV families showing a monoclonal/oligoclonal distribution. During HAART a normalization of the TCR repertoire in both CD8 and CD4 subsets occurred. TCR repertoire normalization was associated with a good virological and immunological response. Conclusion: These results suggest that complete and early virus replication control as a result of early HAART leads to a marked reduction of T-cell oligoclonality and is an essential prerequisite to the development of a polyclonal immune response in HIV-1 infected infants.
KW - HAART
KW - Immune reconstitution
KW - Paediatrics
KW - T-cell repertoire
KW - Vertical HIV-1 infection
UR - http://www.scopus.com/inward/record.url?scp=0035834471&partnerID=8YFLogxK
U2 - 10.1097/00002030-200111090-00002
DO - 10.1097/00002030-200111090-00002
M3 - Article
C2 - 11684926
AN - SCOPUS:0035834471
SN - 0269-9370
VL - 15
SP - 2075
EP - 2084
JO - AIDS
JF - AIDS
IS - 16
ER -